Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
57 studies found for:    "narcolepsy"
Show Display Options
RSS Create an RSS feed from your search for:
"narcolepsy"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Armodafinil
2 Terminated Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: GSK189254
3 Completed
Has Results
Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Xyrem (sodium oxybate) oral solution
4 Completed A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: JNJ-17216498;   Drug: Modafinil
5 Completed
Has Results
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Xyrem;   Drug: Xyrem Placebo;   Drug: Modafinil at established dose;   Drug: Modafinil (Placebo)
6 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Modafinil
7 Completed
Has Results
Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
Condition: Narcolepsy
Intervention: Biological: A/H1N1 vaccine
8 Recruiting A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy
Condition: Narcolepsy
Intervention:
9 Completed
Has Results
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
10 Active, not recruiting "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"
Condition: Narcolepsy
Intervention: Drug: JZP-110
11 Completed Body Weight Regulation in Patients With Narcolepsy
Condition: Narcolepsy
Intervention:
12 Completed
Has Results
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Armodafinil;   Drug: Placebo
13 Recruiting Xyrem and Brain Dopamine in Narcolepsy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
14 Completed Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Condition: Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Interventions: Drug: BF2.649;   Drug: Vigil;   Drug: palcebo
15 Recruiting Metabolism Characteristics in the Children With Narcolepsy
Condition: Narcolepsy
Intervention: Other: Sleep and metabolism assessment
16 Active, not recruiting Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
Conditions: Narcolepsy;   Cataplexy
Intervention: Drug: BF2.649
17 Completed
Has Results
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Interventions: Drug: Placebo;   Drug: PF-03654746
18 Unknown  Narcolepsy - New Potential Treatment
Condition: Narcolepsy
Interventions: Device: Kinetic Oscillation Stimulation Device;   Device: Kinetic Oscillation Stimulation Device in placebo mode
19 Completed Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition: Narcolepsy
Intervention: Drug: sodium oxybate
20 Recruiting Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Sleepiness
Interventions: Drug: JZP-110;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.